Social Anxiety Telehealth Therapy Study

Overview

The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 1, 2021

Interventions

  • Behavioral: Telehealth CBT
    • The Coordinated Anxiety Learning and Management (CALM) program is an evidence-based, computer-assisted protocol for cognitive behavioral therapy (CBT) for anxiety, depression, and/or post-traumatic stress. CALM will be implemented via secure and HIPAA compliant video-conferencing software (enterprise Zoom), following modifications to address obstacles associated with physical distancing and the tele-health medium.

Arms, Groups and Cohorts

  • Experimental: Telehealth Therapy

Clinical Trial Outcome Measures

Primary Measures

  • Liebowitz Social Anxiety Scale (LSAS)
    • Time Frame: 12 weeks
    • Social anxiety severity
  • Satisfaction with Therapy and Therapists Scale (STTS)
    • Time Frame: 12 weeks
    • Therapy satisfaction subscale
  • UCLA Loneliness Scale version 3
    • Time Frame: 12 weeks
    • Loneliness

Secondary Measures

  • Liebowitz Social Anxiety Scale (LSAS)
    • Time Frame: 24 weeks
    • Social anxiety severity
  • UCLA Loneliness Scale version 3
    • Time Frame: 24 weeks
    • Loneliness

Participating in This Clinical Trial

Inclusion Criteria

  • Age 18+,
  • Liebowitz Social Anxiety Scale (LSAS) total score > 50
  • Fluent spoken and written English
  • Access to the internet via a smartphone or computer with a camera
  • Ability to provide informed consent.

Exclusion Criteria

  • History of mania or psychosis
  • Moderate or severe substance use disorder within the past year
  • Current psychiatric diagnosis of greater impairment than that arising from social anxiety
  • High risk for suicide (>8 on the Mini International Neuropsychiatric Interview suicidality section)
  • Prior exposure therapy (more than 2 sessions)
  • Current psychotropic medication use
  • Current psychotherapy other than couples counseling.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Stanford University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Tali Manber Ball, PhD, Instructor – Stanford University
  • Overall Official(s)
    • Tali Ball, PhD, Principal Investigator, Stanford University
  • Overall Contact(s)
    • Tali Ball, PhD, 650-723-2686, anxiety_research@stanford.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.